BCTXL
What one share of Briacell Therapeutics holds
Pharmaceutical Preparations
Briacell Therapeutics’s numbers from its SEC filings, divided by its shares. Results cover the last 12 months to 2026-04-30; the balance sheet is as of 2026-04-30.
| Profit | −$9.66 |
|---|---|
| Cash and investments | $0.95 |
| Book value | $3.23 |
Per share by fiscal year
| Year | Sales | Profit | Capex | Free cash | Dividends | Book value |
|---|---|---|---|---|---|---|
| 2022 | — | −$259.83 | — | −$120.86 | — | $99.84 |
| 2023 | — | −$194.97 | — | −$228.03 | — | −$35.45 |
| 2024 | — | −$43.68 | $4.16 | −$224.09 | — | −$22.02 |
| 2025 | — | −$62.19 | — | −$66.58 | — | $9.20 |